Priority Date: 27.11.09 (US 20090264748P)

Genz 112638 for treating Gaucher or Fabry disease in combination therapy

  • Application ID: EP14164650
  • Status: NO OPPOSITION FILED WITHIN TIMELIMIT

Applicant

Technology company logo small
Technology Company

Attorneys

no operation time available
Headquarter in London and 5 offices
active in Legal Services and Matchmaking and Trading
Employment test 51 - 200 employees
Company dna potter clarkson llp
operating since 1889
Headquarter in Nottingham and 1 office
active in Legal Services, IP Consulting, and IP Portfolio Processing

Specialization

This patent has the IPC combination A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C07 (ORGANIC CHEMISTRY) Potter Clarkson LLP and Mathys & Squire LLP are specialized in the combination A61 and C07. We found, that TransMIT GmbH, Kailuweit & Uhlemann, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB and 188 others are specialized in all of these IPC classes as well. For a similar patent, they might be a good choice.

Timeline

  • 27.11.2009 - Priority Date (US 20090264748P)
  • 29.10.2014 - Publication A1 (EP2796457)
  • 18.05.2016 - Publication B1 (EP2796457)

IPC Classification